Sector: Healthcare | Industry: Managed Health Care |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 200 Oceangate, Suite 100 LONG BEACH CA 90802-4317 |
Tel: | 1-562-5494100 |
Website: | https://www.molinahealthcare.com |
IR: | See website |
Key People | ||
Joseph M. Zubretsky President, Chief Executive Officer, Director | Mark L. Keim Chief Financial Officer | James E. Woys Chief Operating Officer |
Debra J. Bacon Executive Vice President - Medicaid | Maurice S. Hebert Chief Accounting Officer | Jeffrey D. Barlow Chief Legal Officer, Secretary |
Business Overview |
Molina Healthcare, Inc. is a provider of managed healthcare services under the medicaid and medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. Medicaid provides healthcare and long-term services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over, and some disabled persons, with a variety of hospital, medical insurance, and prescription drug benefits. The Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. It arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies. |
Financial Overview |
For the fiscal year ended 31 December 2023, Molina Healthcare Inc revenues increased 7% to $34.07B. Net income increased 38% to $1.09B. Revenues reflect Medicaid segment increase of 7% to $27.71B, Medical Expense Ratio -%Marketplace decrease of 14% to 75.3%. Net income benefited from Impairment decrease from $208M (expense) to $0K. Basic Earnings per Share excluding Extraordinary Items increased from $13.70 to $18.91. |
Employees: | 18,000 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $14,969M as of Mar 31, 2024 |
Annual revenue (TTM): | $35,854M as of Mar 31, 2024 |
EBITDA (TTM): | $1,774M as of Mar 31, 2024 |
Net annual income (TTM): | $1,071M as of Mar 31, 2024 |
Free cash flow (TTM): | $881.00M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 59,000,000 as of Mar 31, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |